Related Experiment Videos
Design and analytic considerations for single-armed studies with misclassification of a repeated binary outcome
Robert H Lyles1, Hung-Mo Lin, John M Williamson
1Department of Biostatistics, The Rollins School of Public Health of Emory University, Atlanta, Georgia 30322, USA. rlyles@sph.emory.edu
Journal of Biopharmaceutical Statistics
|March 19, 2004
Summary
This study addresses bias in clinical trials caused by misclassified outcomes. It proposes a new design using internal validation data to improve treatment effect estimation in single-armed studies with screening tests.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Epidemiology
Background:
- Clinical studies often use binary outcome variables prone to misclassification due to cost or logistics.
- Single-armed studies with screening-selected participants face bias from misclassification at screening and outcome measurement.
- Ethical considerations sometimes necessitate noncomparative study designs.
Purpose of the Study:
- To propose a robust study design for mitigating bias in treatment effect estimation.
- To introduce a method for collecting internal validation data using a gold standard outcome measure.
- To optimize the allocation of observations within a validation study to minimize variance.
Main Methods:
- Likelihood-based analysis for treatment effect estimation.
- Development of a study design incorporating internal validation data.
- Identification and analysis of four types of validation study observations.
- Exploration of efficiency considerations for ratio and difference measures of treatment effect.
Main Results:
- The proposed design effectively addresses bias from screening and outcome misclassification.
- Optimal allocation of validation data is crucial for minimizing estimated treatment effect variance.
- The optimal allocation strategy depends on whether a ratio or difference measure is used.
- Numerical illustrations and a real-life example demonstrate the proposed methods.
Conclusions:
- The proposed study design enhances the accuracy of treatment effect estimation in challenging clinical settings.
- Internal validation data collection and optimal allocation are key to reliable results.
- The choice of treatment effect measure significantly influences the optimal design strategy.